Every SEC Form 3/4/5 on record for this filer (CIK 1629383) — 8 issuers, 91 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| CTNM | Contineum Therapeutics, Inc. | Director | 2024-06-24 → 2026-06-26 | 4 | — |
| RNA | Atrium Therapeutics, Inc. | Director | 2020-06-11 → 2026-03-02 | 30 | −$33M |
| RNAM | Avidity Biosciences, Inc. | President and CEO · Director | 2026-02-27 → 2026-02-27 | 1 | — |
| OABI | OmniAb, Inc. | Director · lapsed | 2022-11-03 → 2024-06-21 | 7 | $101,340 |
| LGND | LIGAND PHARMACEUTICALS INC | Filer · lapsed | 2019-10-15 → 2022-11-03 | 6 | — |
| BLI | Berkeley Lights, Inc. | Director · lapsed | 2020-07-16 → 2021-05-18 | 3 | −$611,340 |
| AKCA | AKCEA THERAPEUTICS, INC. | President · Director · lapsed | 2018-04-18 → 2019-07-17 | 5 | −$42,783 |
| IONS | IONIS PHARMACEUTICALS INC | Chief Business Officer · lapsed | 2016-01-04 → 2018-01-17 | 8 | −$212,819 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| RNA | 2026-01-21 | Sell | 7,993 | $72.45 | $579,093 | 269,007 |
| RNA | 2026-01-21 | Sell | 6,394 | $72.45 | $463,245 | 277,000 |
| RNA | 2026-01-07 | Sell | 8,576 | $72.23 | $619,444 | 283,394 |
| RNA | 2025-09-05 | Sell | 50,000 | $49.95 | $2M | 305,871 |
| RNA | 2025-08-28 | Sell | 25,000 | $49.39 | $1M | 305,871 |
5 of 8 issuers are covered and open a security page; the rest are on file here only.
